Efficacy & Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder

This study has been completed.
Sponsor:
Information provided by:
AstraZeneca
ClinicalTrials.gov Identifier:
NCT00107731
First received: April 7, 2005
Last updated: March 24, 2009
Last verified: March 2009
  Purpose

The purpose of this study is to determine whether quetiapine when used as adjunct to lithium or divalproex is safe and effective in the maintenance treatment of adult patients with Bipolar I Disorder. The study consists of enrollment and 2 phases, the Open-label treatment Phase and the Randomized treatment Phase.

PLEASE NOTE: Seroquel SR and Seroquel XR refer to the same formulation. The SR designation was changed to XR after consultation with FDA.


Condition Intervention Phase
Bipolar I Disorder
Drug: quetiapine fumarate
Drug: lithium
Drug: divalproex
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double-Blind
Primary Purpose: Prevention
Official Title: A Multicenter, Randomized, Parallel-Group, Double-Blind, Phase 3 Comparison of the Efficacy & Safety of Quetiapine Fumarate to Placebo When Used as Adjunct to Mood Stabilizers (Lithium or Valproate) in the Maintenance Treatment of Bipolar I Disorder in Adult Patients (Abbreviated)

Resource links provided by NLM:


Further study details as provided by AstraZeneca:

Primary Outcome Measures:
  • Evaluate the efficacy of quetiapine versus placebo when used as adjunct therapy to mood stabilizer in increasing time to recurrence of a mood event.

Secondary Outcome Measures:
  • Evaluate the efficacy of quetiapine versus placebo when used as a adjunct therapy to mod stabilizer in increasing time to recurrence of a manic event

Estimated Enrollment: 710
Study Start Date: April 2004
Study Completion Date: October 2006
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • A diagnosis of Bipolar I Disorder, Most recent episode Manic (296.4x), or Bipolar I Disorder, Most Recent Episode Depressed (296.5x), or Bipolar I Disorder, Most recent Episode Mixed (296.6x), with or without psychotic features, as defined by Diagnostic and Statistical Manual of Mental Disorders - Fourth Edition (DSM-IV)
  • At least 1 manic, depressed, or mixed episode in the 2 years prior to the index episode.
  • Able to understand and comply with the requirements of the study.

Exclusion Criteria:

  • Diagnosis of an anxiety disorder as defined by DSM-IV, which was treated with medication within the past year.
  • Known intolerance or lack of response to quetiapine fumarate or to the assigned mood stabilizer, as judged by the investigator.
  • Previously randomized into this study or D1447C00126
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00107731

  Hide Study Locations
Locations
United States, Alabama
Research Site
Birmingham, Alabama, United States
United States, California
Research Site
Beverly Hills, California, United States
Research Site
Chula Vista, California, United States
Research Site
Redlands, California, United States
Research Site
San Francisco, California, United States
Research Site
Santa Ana, California, United States
United States, Florida
Research Site
Gainesville, Florida, United States
Research Site
Jacksonville, Florida, United States
Research Site
Miami, Florida, United States
Research Site
Sarasota, Florida, United States
Research Site
Tampa, Florida, United States
Research Site
Winter Park, Florida, United States
United States, Illinois
Research Site
Granite City, Illinois, United States
Research Site
Libertyville, Illinois, United States
Research Site
Schaumburg, Illinois, United States
United States, Kansas
Research Site
Wichita, Kansas, United States
United States, Louisiana
Research Site
Metairie, Louisiana, United States
United States, Maryland
Research Site
Glen Burnie, Maryland, United States
United States, Michigan
Research Site
Kalamazoo, Michigan, United States
United States, Missouri
Research Site
St. Charles, Missouri, United States
Research Site
St. Louis, Missouri, United States
United States, New York
Research Site
Brooklyn, New York, United States
Research Site
Olean, New York, United States
Research Site
Rochester, New York, United States
United States, North Carolina
Research Site
Morganton, North Carolina, United States
Research Site
Raleigh, North Carolina, United States
United States, Oklahoma
Research Site
Oklahoma City, Oklahoma, United States
United States, Oregon
Research Site
Portland, Oregon, United States
United States, Pennsylvania
Research Site
Havertown, Pennsylvania, United States
Research Site
Media, Pennsylvania, United States
Research Site
Philadelphia, Pennsylvania, United States
United States, Texas
Research Site
Conroe, Texas, United States
Research Site
Houston, Texas, United States
United States, Virginia
Research Site
Richmond, Virginia, United States
United States, Washington
Research Site
Seattle, Washington, United States
United States, Wisconsin
Research Site
Milwaukee, Wisconsin, United States
Australia, New South Wales
Research Site
Greenwich, New South Wales, Australia
Australia, Queensland
Research Site
Brisbane, Queensland, Australia
Research Site
Everton Park, Queensland, Australia
Research Site
Southport, Queensland, Australia
Australia, South Australia
Research Site
Glenside, South Australia, Australia
Australia, Victoria
Research Site
Box Hill, Victoria, Australia
Research Site
Dandenong, Victoria, Australia
Research Site
Epping, Victoria, Australia
Research Site
Richmond, Victoria, Australia
Belgium
Research Site
Assebroek, Belgium
Research Site
Brussels, Belgium
Research Site
Gent, Belgium
Research Site
Kortenberg, Belgium
Research Site
Manage, Belgium
Research Site
St-Denijs-Westrem, Belgium
Research Site
Waregem, Belgium
Bulgaria
Research Site
Kardjali, Bulgaria
Research Site
Rousse, Bulgaria
Research Site
Sofia, Bulgaria
Research Site
Varna, Bulgaria
Czech Republic
Research Site
Jeseník, Czech Republic
Research Site
Litomolice, Czech Republic
Research Site
Olomouc, Czech Republic
Research Site
Praha 10, Czech Republic
Research Site
Praha 2, Czech Republic
Research Site
Praha 6, Czech Republic
Research Site
Praha 8, Czech Republic
Research Site
Pterova, Czech Republic
Finland
Research Site
Espoo, Finland
Research Site
Harjavalta, Finland
Research Site
Helsinki, Finland
Research Site
Kellokoski, Finland
Research Site
Seinajoki, Finland
France
Research Site
Besancon, France
Research Site
Bourg En Bresse, France
Research Site
La Rochelle Cedex 1, France
Research Site
Marseille Cedex 9, France
Research Site
Montpellier, France
Research Site
NIMES Cedex 4, France
Research Site
Paris Cedex 12, France
Research Site
Strasbourg Cedex, France
Research Site
Toulouse, France
Germany
Research Site
Augsburg, Germany
Research Site
Berlin, Germany
Research Site
Heidelberg, Germany
Research Site
Homburg, Germany
Research Site
Köln, Germany
Research Site
München, Germany
Research Site
Regensburg, Germany
Research Site
Saarbrucken, Germany
Hungary
Research Site
Budapest, Hungary
Research Site
Fuzesabony, Hungary
Research Site
Gyor, Hungary
Research Site
Kecskemet, Hungary
Research Site
Kistarcsa, Hungary
Research Site
Pecs, Hungary
Italy
Research Site
Bari, Italy
Research Site
Bergamo, Italy
Research Site
Brescia, Italy
Research Site
Cagliari, Italy
Research Site
Civitanova Marche, Italy
Research Site
Firenze, Italy
Research Site
Genova, Italy
Research Site
La Spezia, Italy
Research Site
Milano, Italy
Research Site
Napoli, Italy
Research Site
Padova, Italy
Research Site
Pisa, Italy
Research Site
Roma, Italy
Research Site
Siena, Italy
Research Site
Trieste, Italy
Norway
Research Site
Bergen, Norway
Research Site
Bodo, Norway
Research Site
Bryne, Norway
Research Site
Namsos, Norway
Research Site
Oslo, Norway
Research Site
Ottestad, Norway
Research Site
Skien, Norway
Poland
Research Site
Bialystok, Poland
Research Site
Bydgoszcz, Poland
Research Site
Choroszcz, Poland
Research Site
Gdansk, Poland
Research Site
Gorlice, Poland
Research Site
Janów Lubelski, Poland
Research Site
Krakow, Poland
Research Site
Lipno, Poland
Research Site
Lodz, Poland
Research Site
Lublin, Poland
Research Site
Nowy Targ, Poland
Research Site
Poznan, Poland
Research Site
Starogard Gdanski, Poland
Research Site
Szczecin, Poland
Research Site
Torun, Poland
Research Site
Warszawa, Poland
Research Site
Zubki, Poland
Russian Federation
Research Site
Moscow, Russian Federation
Research Site
Saratov, Russian Federation
Research Site
St. Petersburg, Russian Federation
South Africa
Research Site
Bloemfontein, South Africa
Research Site
Durban, South Africa
Research Site
Johannesburg, South Africa
Research Site
Krugersdorp, South Africa
Research Site
Pretoria, South Africa
Spain
Research Site
Oviedo, Asturias, Spain
Research Site
Sama de Langreo, Asturias, Spain
Research Site
Terrassa, Barcelona, Spain
Research Site
Puerto Real, Cádiz, Spain
Research Site
Barcelona, Spain
Research Site
Bilbao, Spain
Research Site
Granada, Spain
Research Site
Guadalajara, Spain
Research Site
Madrid, Spain
Research Site
Oviedo, Spain
Research Site
Santiago de Compostela, Spain
Research Site
Sevilla, Spain
Research Site
Vigo, Spain
Sweden
Research Site
Falkoping, Sweden
Research Site
Linköping, Sweden
Research Site
Ludvika, Sweden
Research Site
Sollentuna, Sweden
Research Site
Stockholm, Sweden
Research Site
Sundsvall, Sweden
Turkey
Research Site
Adana, Turkey
Research Site
Ankara, Turkey
Research Site
Istanbul, Turkey
Research Site
Izmir, Turkey
United Kingdom
Research Site
Birmingham, United Kingdom
Research Site
London, United Kingdom
Research Site
Oxford, United Kingdom
Research Site
Runcorn, United Kingdom
Research Site
Ryhope, United Kingdom
Research Site
Surbiton, United Kingdom
Research Site
Welwyn Garden City, United Kingdom
Sponsors and Collaborators
AstraZeneca
Investigators
Study Director: AstraZeneca Seroquel Medical Science Director, MD AstraZeneca
  More Information

No publications provided by AstraZeneca

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: NCT00107731     History of Changes
Other Study ID Numbers: D1447C00126
Study First Received: April 7, 2005
Last Updated: March 24, 2009
Health Authority: United States: Food and Drug Administration

Keywords provided by AstraZeneca:
Bipolar I Disorder
Manic Depressive Disorder
Manic Depression

Additional relevant MeSH terms:
Lithium
Quetiapine
Antipsychotic Agents
Tranquilizing Agents
Central Nervous System Depressants
Physiological Effects of Drugs
Pharmacologic Actions
Central Nervous System Agents
Therapeutic Uses
Psychotropic Drugs
Antimanic Agents

ClinicalTrials.gov processed this record on August 21, 2014